Cargando…
Imetelstat (a telomerase antagonist) exerts off-target effects on the cytoskeleton
Telomerase is a cellular ribonucleoprotein reverse transcriptase that plays a crucial role in telomere maintenance. This enzyme is expressed in approximately 90% of human tumors, but not in the majority of normal somatic cells. Imetelstat sodium (GRN163L), is a 13-mer oligonucleotide N3′→P5′ thio-ph...
Autores principales: | MENDER, ILGEN, SENTURK, SERIF, OZGUNES, NURIMAN, AKCALI, K. CAN, KLETSAS, DIMITRIS, GRYAZNOV, SERGEI, CAN, ALP, SHAY, JERRY W., DIKMEN, Z. GUNNUR |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4738197/ https://www.ncbi.nlm.nih.gov/pubmed/23545855 http://dx.doi.org/10.3892/ijo.2013.1865 |
Ejemplares similares
-
A novel telomerase substrate precursor rapidly induces telomere dysfunction in telomerase positive cancer cells but not telomerase silent normal cells
por: Mender, Ilgen, et al.
Publicado: (2015) -
Activating an Adaptive Immune Response with a Telomerase-Mediated Telomere Targeting Therapeutic in Hepatocellular Carcinoma
por: Mender, Ilgen, et al.
Publicado: (2023) -
Telomerase antagonist imetelstat increases radiation sensitivity in esophageal squamous cell carcinoma
por: Wu, Xuping, et al.
Publicado: (2017) -
Telomerase inhibitor imetelstat has preclinical activity across the spectrum of non-small cell lung cancer oncogenotypes in a telomere length dependent manner
por: Frink, Robin E., et al.
Publicado: (2016) -
Telomerase Inhibitor Imetelstat (GRN163L) Limits the Lifespan of Human Pancreatic Cancer Cells
por: Burchett, Katrina M., et al.
Publicado: (2014)